Global Somatostatin Drugs Supply, Demand and Key Producers, 2024-2030

Description

The global Somatostatin Drugs market size is expected to reach $ 184.7 million by 2030, rising at a market growth of -5.4% CAGR during the forecast period (2024-2030).

The Somatostatin Drugs market is primarily driven by the increasing demand for targeted therapies to manage conditions related to hormone overproduction and tumor growth. Somatostatin drugs, such as octreotide and lanreotide, are used to inhibit the excessive release of certain hormones and control symptoms associated with conditions like acromegaly, carcinoid syndrome, and pituitary tumors. The growing prevalence of hormone-related disorders, coupled with advancements in endocrinology and medical imaging, contributes to market growth. Moreover, the demonstrated efficacy of somatostatin drugs in symptom relief and tumor size reduction further propels adoption. However, challenges include optimizing dosing regimens for individual patients and addressing potential side effects or interactions. Navigating patient-specific treatment needs, ensuring long-term safety and monitoring, and managing potential injection site reactions are ongoing concerns. The market's success relies on continuous research into endocrine disorders, collaborations between pharmaceutical manufacturers and endocrinologists, and comprehensive patient education on the benefits and potential risks of somatostatin drug treatments while addressing the evolving challenges associated with hormone-related conditions and treatment accessibility.

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

This report studies the global Somatostatin Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Somatostatin Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Somatostatin Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Somatostatin Drugs total production and demand, 2019-2030, (K Units)
Global Somatostatin Drugs total production value, 2019-2030, (USD Million)
Global Somatostatin Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Somatostatin Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Somatostatin Drugs domestic production, consumption, key domestic manufacturers and share
Global Somatostatin Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Somatostatin Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Somatostatin Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Somatostatin Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Pfizer, Ispen, HYBIO and TianTaiShan, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Somatostatin Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Somatostatin Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Somatostatin Drugs Market, Segmentation by Type
    Octreotide
    Lanreotide
    Pasireotide
    Other

Global Somatostatin Drugs Market, Segmentation by Application
    Hospital
    Pharmacy
    Other

Companies Profiled:
    Novartis
    Pfizer
    Ispen
    HYBIO
    TianTaiShan

Key Questions Answered
1. How big is the global Somatostatin Drugs market?
2. What is the demand of the global Somatostatin Drugs market?
3. What is the year over year growth of the global Somatostatin Drugs market?
4. What is the production and production value of the global Somatostatin Drugs market?
5. Who are the key producers in the global Somatostatin Drugs market?

Table of Contents

1 Supply Summary
    1.1 Somatostatin Drugs Introduction
    1.2 World Somatostatin Drugs Supply & Forecast
        1.2.1 World Somatostatin Drugs Production Value (2019 & 2023 & 2030)
        1.2.2 World Somatostatin Drugs Production (2019-2030)
        1.2.3 World Somatostatin Drugs Pricing Trends (2019-2030)
    1.3 World Somatostatin Drugs Production by Region (Based on Production Site)
        1.3.1 World Somatostatin Drugs Production Value by Region (2019-2030)
        1.3.2 World Somatostatin Drugs Production by Region (2019-2030)
        1.3.3 World Somatostatin Drugs Average Price by Region (2019-2030)
        1.3.4 North America Somatostatin Drugs Production (2019-2030)
        1.3.5 Europe Somatostatin Drugs Production (2019-2030)
        1.3.6 China Somatostatin Drugs Production (2019-2030)
        1.3.7 Japan Somatostatin Drugs Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Somatostatin Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Somatostatin Drugs Major Market Trends

2 Demand Summary
    2.1 World Somatostatin Drugs Demand (2019-2030)
    2.2 World Somatostatin Drugs Consumption by Region
        2.2.1 World Somatostatin Drugs Consumption by Region (2019-2024)
        2.2.2 World Somatostatin Drugs Consumption Forecast by Region (2025-2030)
    2.3 United States Somatostatin Drugs Consumption (2019-2030)
    2.4 China Somatostatin Drugs Consumption (2019-2030)
    2.5 Europe Somatostatin Drugs Consumption (2019-2030)
    2.6 Japan Somatostatin Drugs Consumption (2019-2030)
    2.7 South Korea Somatostatin Drugs Consumption (2019-2030)
    2.8 ASEAN Somatostatin Drugs Consumption (2019-2030)
    2.9 India Somatostatin Drugs Consumption (2019-2030)

3 World Somatostatin Drugs Manufacturers Competitive Analysis
    3.1 World Somatostatin Drugs Production Value by Manufacturer (2019-2024)
    3.2 World Somatostatin Drugs Production by Manufacturer (2019-2024)
    3.3 World Somatostatin Drugs Average Price by Manufacturer (2019-2024)
    3.4 Somatostatin Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Somatostatin Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Somatostatin Drugs in 2023
        3.5.3 Global Concentration Ratios (CR8) for Somatostatin Drugs in 2023
    3.6 Somatostatin Drugs Market: Overall Company Footprint Analysis
        3.6.1 Somatostatin Drugs Market: Region Footprint
        3.6.2 Somatostatin Drugs Market: Company Product Type Footprint
        3.6.3 Somatostatin Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Somatostatin Drugs Production Value Comparison
        4.1.1 United States VS China: Somatostatin Drugs Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Somatostatin Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Somatostatin Drugs Production Comparison
        4.2.1 United States VS China: Somatostatin Drugs Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Somatostatin Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Somatostatin Drugs Consumption Comparison
        4.3.1 United States VS China: Somatostatin Drugs Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Somatostatin Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Somatostatin Drugs Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Somatostatin Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Somatostatin Drugs Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Somatostatin Drugs Production (2019-2024)
    4.5 China Based Somatostatin Drugs Manufacturers and Market Share
        4.5.1 China Based Somatostatin Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Somatostatin Drugs Production Value (2019-2024)
        4.5.3 China Based Manufacturers Somatostatin Drugs Production (2019-2024)
    4.6 Rest of World Based Somatostatin Drugs Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Somatostatin Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Somatostatin Drugs Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Somatostatin Drugs Production (2019-2024)

5 Market Analysis by Type
    5.1 World Somatostatin Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Octreotide
        5.2.2 Lanreotide
        5.2.3 Pasireotide
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Somatostatin Drugs Production by Type (2019-2030)
        5.3.2 World Somatostatin Drugs Production Value by Type (2019-2030)
        5.3.3 World Somatostatin Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Somatostatin Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Somatostatin Drugs Production by Application (2019-2030)
        6.3.2 World Somatostatin Drugs Production Value by Application (2019-2030)
        6.3.3 World Somatostatin Drugs Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis Somatostatin Drugs Product and Services
        7.1.4 Novartis Somatostatin Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Somatostatin Drugs Product and Services
        7.2.4 Pfizer Somatostatin Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 Ispen
        7.3.1 Ispen Details
        7.3.2 Ispen Major Business
        7.3.3 Ispen Somatostatin Drugs Product and Services
        7.3.4 Ispen Somatostatin Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Ispen Recent Developments/Updates
        7.3.6 Ispen Competitive Strengths & Weaknesses
    7.4 HYBIO
        7.4.1 HYBIO Details
        7.4.2 HYBIO Major Business
        7.4.3 HYBIO Somatostatin Drugs Product and Services
        7.4.4 HYBIO Somatostatin Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 HYBIO Recent Developments/Updates
        7.4.6 HYBIO Competitive Strengths & Weaknesses
    7.5 TianTaiShan
        7.5.1 TianTaiShan Details
        7.5.2 TianTaiShan Major Business
        7.5.3 TianTaiShan Somatostatin Drugs Product and Services
        7.5.4 TianTaiShan Somatostatin Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 TianTaiShan Recent Developments/Updates
        7.5.6 TianTaiShan Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Somatostatin Drugs Industry Chain
    8.2 Somatostatin Drugs Upstream Analysis
        8.2.1 Somatostatin Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Somatostatin Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Somatostatin Drugs Production Mode
    8.6 Somatostatin Drugs Procurement Model
    8.7 Somatostatin Drugs Industry Sales Model and Sales Channels
        8.7.1 Somatostatin Drugs Sales Model
        8.7.2 Somatostatin Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Somatostatin Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Somatostatin Drugs Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Somatostatin Drugs Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Somatostatin Drugs Production Value Market Share by Region (2019-2024)
    Table 5. World Somatostatin Drugs Production Value Market Share by Region (2025-2030)
    Table 6. World Somatostatin Drugs Production by Region (2019-2024) & (K Units)
    Table 7. World Somatostatin Drugs Production by Region (2025-2030) & (K Units)
    Table 8. World Somatostatin Drugs Production Market Share by Region (2019-2024)
    Table 9. World Somatostatin Drugs Production Market Share by Region (2025-2030)
    Table 10. World Somatostatin Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 11. World Somatostatin Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 12. Somatostatin Drugs Major Market Trends
    Table 13. World Somatostatin Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Somatostatin Drugs Consumption by Region (2019-2024) & (K Units)
    Table 15. World Somatostatin Drugs Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Somatostatin Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Somatostatin Drugs Producers in 2023
    Table 18. World Somatostatin Drugs Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Somatostatin Drugs Producers in 2023
    Table 20. World Somatostatin Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 21. Global Somatostatin Drugs Company Evaluation Quadrant
    Table 22. World Somatostatin Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Somatostatin Drugs Production Site of Key Manufacturer
    Table 24. Somatostatin Drugs Market: Company Product Type Footprint
    Table 25. Somatostatin Drugs Market: Company Product Application Footprint
    Table 26. Somatostatin Drugs Competitive Factors
    Table 27. Somatostatin Drugs New Entrant and Capacity Expansion Plans
    Table 28. Somatostatin Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Somatostatin Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Somatostatin Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Somatostatin Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Somatostatin Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Somatostatin Drugs Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Somatostatin Drugs Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Somatostatin Drugs Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Somatostatin Drugs Production Market Share (2019-2024)
    Table 37. China Based Somatostatin Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Somatostatin Drugs Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Somatostatin Drugs Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Somatostatin Drugs Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Somatostatin Drugs Production Market Share (2019-2024)
    Table 42. Rest of World Based Somatostatin Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Somatostatin Drugs Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Somatostatin Drugs Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Somatostatin Drugs Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Somatostatin Drugs Production Market Share (2019-2024)
    Table 47. World Somatostatin Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Somatostatin Drugs Production by Type (2019-2024) & (K Units)
    Table 49. World Somatostatin Drugs Production by Type (2025-2030) & (K Units)
    Table 50. World Somatostatin Drugs Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Somatostatin Drugs Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Somatostatin Drugs Average Price by Type (2019-2024) & (USD/Unit)
    Table 53. World Somatostatin Drugs Average Price by Type (2025-2030) & (USD/Unit)
    Table 54. World Somatostatin Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Somatostatin Drugs Production by Application (2019-2024) & (K Units)
    Table 56. World Somatostatin Drugs Production by Application (2025-2030) & (K Units)
    Table 57. World Somatostatin Drugs Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Somatostatin Drugs Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Somatostatin Drugs Average Price by Application (2019-2024) & (USD/Unit)
    Table 60. World Somatostatin Drugs Average Price by Application (2025-2030) & (USD/Unit)
    Table 61. Novartis Basic Information, Manufacturing Base and Competitors
    Table 62. Novartis Major Business
    Table 63. Novartis Somatostatin Drugs Product and Services
    Table 64. Novartis Somatostatin Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Novartis Recent Developments/Updates
    Table 66. Novartis Competitive Strengths & Weaknesses
    Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 68. Pfizer Major Business
    Table 69. Pfizer Somatostatin Drugs Product and Services
    Table 70. Pfizer Somatostatin Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Pfizer Recent Developments/Updates
    Table 72. Pfizer Competitive Strengths & Weaknesses
    Table 73. Ispen Basic Information, Manufacturing Base and Competitors
    Table 74. Ispen Major Business
    Table 75. Ispen Somatostatin Drugs Product and Services
    Table 76. Ispen Somatostatin Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Ispen Recent Developments/Updates
    Table 78. Ispen Competitive Strengths & Weaknesses
    Table 79. HYBIO Basic Information, Manufacturing Base and Competitors
    Table 80. HYBIO Major Business
    Table 81. HYBIO Somatostatin Drugs Product and Services
    Table 82. HYBIO Somatostatin Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. HYBIO Recent Developments/Updates
    Table 84. TianTaiShan Basic Information, Manufacturing Base and Competitors
    Table 85. TianTaiShan Major Business
    Table 86. TianTaiShan Somatostatin Drugs Product and Services
    Table 87. TianTaiShan Somatostatin Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 88. Global Key Players of Somatostatin Drugs Upstream (Raw Materials)
    Table 89. Somatostatin Drugs Typical Customers
    Table 90. Somatostatin Drugs Typical Distributors
List of Figure
    Figure 1. Somatostatin Drugs Picture
    Figure 2. World Somatostatin Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Somatostatin Drugs Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Somatostatin Drugs Production (2019-2030) & (K Units)
    Figure 5. World Somatostatin Drugs Average Price (2019-2030) & (USD/Unit)
    Figure 6. World Somatostatin Drugs Production Value Market Share by Region (2019-2030)
    Figure 7. World Somatostatin Drugs Production Market Share by Region (2019-2030)
    Figure 8. North America Somatostatin Drugs Production (2019-2030) & (K Units)
    Figure 9. Europe Somatostatin Drugs Production (2019-2030) & (K Units)
    Figure 10. China Somatostatin Drugs Production (2019-2030) & (K Units)
    Figure 11. Japan Somatostatin Drugs Production (2019-2030) & (K Units)
    Figure 12. Somatostatin Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Somatostatin Drugs Consumption (2019-2030) & (K Units)
    Figure 15. World Somatostatin Drugs Consumption Market Share by Region (2019-2030)
    Figure 16. United States Somatostatin Drugs Consumption (2019-2030) & (K Units)
    Figure 17. China Somatostatin Drugs Consumption (2019-2030) & (K Units)
    Figure 18. Europe Somatostatin Drugs Consumption (2019-2030) & (K Units)
    Figure 19. Japan Somatostatin Drugs Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Somatostatin Drugs Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Somatostatin Drugs Consumption (2019-2030) & (K Units)
    Figure 22. India Somatostatin Drugs Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Somatostatin Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Somatostatin Drugs Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Somatostatin Drugs Markets in 2023
    Figure 26. United States VS China: Somatostatin Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Somatostatin Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Somatostatin Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Somatostatin Drugs Production Market Share 2023
    Figure 30. China Based Manufacturers Somatostatin Drugs Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Somatostatin Drugs Production Market Share 2023
    Figure 32. World Somatostatin Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Somatostatin Drugs Production Value Market Share by Type in 2023
    Figure 34. Octreotide
    Figure 35. Lanreotide
    Figure 36. Pasireotide
    Figure 37. Other
    Figure 38. World Somatostatin Drugs Production Market Share by Type (2019-2030)
    Figure 39. World Somatostatin Drugs Production Value Market Share by Type (2019-2030)
    Figure 40. World Somatostatin Drugs Average Price by Type (2019-2030) & (USD/Unit)
    Figure 41. World Somatostatin Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 42. World Somatostatin Drugs Production Value Market Share by Application in 2023
    Figure 43. Hospital
    Figure 44. Pharmacy
    Figure 45. Other
    Figure 46. World Somatostatin Drugs Production Market Share by Application (2019-2030)
    Figure 47. World Somatostatin Drugs Production Value Market Share by Application (2019-2030)
    Figure 48. World Somatostatin Drugs Average Price by Application (2019-2030) & (USD/Unit)
    Figure 49. Somatostatin Drugs Industry Chain
    Figure 50. Somatostatin Drugs Procurement Model
    Figure 51. Somatostatin Drugs Sales Model
    Figure 52. Somatostatin Drugs Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Companies Mentioned

Novartis
Pfizer
Ispen
HYBIO
TianTaiShan